Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Bayer, Ole ^a   Reinhart, Konrad ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

ACUTE KIDNEY FAILURE; CRITICALLY ILL PATIENT; CRYSTALLOID; FLUID RESUSCITATION; HEART OUTPUT; HEART SURGERY; HUMAN; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RISK FACTOR; SURGICAL PATIENT; CHEMICALLY INDUCED; FEMALE; MALE; POSTOPERATIVE COMPLICATION;

ACUTE KIDNEY INJURY; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; MALE; PLASMA SUBSTITUTES; POSTOPERATIVE COMPLICATIONS;

EID: 84928718204     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0859-z     Document Type: Letter

References (9)

1. Rioux JP, Lessard M, de Bortoli B, Roy P, Albert M, Verdant C, et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med. 2009;37:1293-8.
2. Frenette AJ, Bouchard J, Bernier P, Charbonneau A, Nguyen LT, Rioux J-P, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014;18:602.
3. Bayer O, Schwarzkopf D, Doenst T, Cook D, Kabisch B, Schelenz C, et al. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery - a prospective sequential analysis. Crit Care Med. 2013;41:2532-42.
4. Wilkes MM, Navickis RJ. Postoperative renal replacement therapy after hydroxyethyl starch infusion: a meta-analysis of randomized trials. Neth J Crit Care. 2014;18:4-9.
5. Hartog CS, Natanson C, Sun J, Klein HG, Reinhart K. Concerns over use of hydroxyethyl starch solutions. BMJ. 2014;349:g5981.
6. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-11.
7. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124-34.
8. Pro CI, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683-93.
9. Investigators RRTS, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med. 2012;40:1753-60.